Sponsor Check › Sponsor group
3 issuers linked to one sponsor · TORRANCE, CA
Grouped because: 9 shared people, similar issuer names (3) (automatic match from the filings) ·Not the same sponsor? Request a correction
Data last updated: Oct 23, 2026, 5:45 PM ET · Latest filing in this group: Jan 31, 2023 · Courts (RECAP) last checked: Oct 24, 2026, 12:52 AM ET · SEC enforcement last checked: not yet
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
1 case: 1 dismissed
850 Securities, Commodities, Exchange
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 24, 2026, 12:52 AM ET. Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
No SEC search has run yet for this sponsor group.
None found in sources searched.
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 12:52 AM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
No public statement by this sponsor group has been collected yet, so there is nothing to compare. Sources compared: the sponsor's own website (known from the issuer's own filings — Form C issuer website, EDGAR company profile — an approved profile claim or Form ADV Item 1.I of its matched adviser) · SEC Form D · SEC Form ADV (IAPD) · Internet Archive · No website is on file for this sponsor group yet.
6 of 29 offerings report sales commissions totalling $2,471,638; 2 report finder's fees totalling $757,500; 2 report proceeds to related persons totalling $1,478,000. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Jan 31, 2023 D File 021-472265 | $0 | $0 | $0 Any proceeds from the exercise of the warrants are expected to be used to augment the issuer's working capital and for general corporate purposes, which could include the payment of compensation to the executive officers and directors of the issuer. | none no CRD number reported |
| EDGAR ↗ | Jan 20, 2023 D File 021-471263 | $0 | $0 | $0 Any proceeds from the exercise of the warrants are expected to be used to augment the issuer's working capital and for general corporate purposes, which could include the payment of compensation to the executive officers and directors of the issuer. | None no CRD number reported |
| EDGAR ↗ | Jun 30, 2022 D File 021-450829 | $0 | $0 | $0 See Item 13 for clarification. | None listed on this filing |
| EDGAR ↗ | Feb 16, 2021 D File 021-389589 | $0 | $0 | $0 (est.) The proceeds of the offering will be used for working capital and general corporate purposes, which could include the payment of salaries to executive officers and director fees. | None no CRD number reported |
| EDGAR ↗ | Oct 9, 2020 D/A File 021-377302 | $0 | $157,500 | $0 (est.) | T.R. Winston & Company LLC BrokerCheck CRD 1415264 ↗ |
| EDGAR ↗ | Aug 7, 2020 D File 021-372773 | $0 | $0 | $0 (est.) | None no CRD number reported |
| EDGAR ↗ | Apr 1, 2019 D File 021-336122 | $600,000 (est.) | $0 | $0 (est.) The net proceeds of the offering will be used for working capital and general corporate purposes, which may include the compensation of named executive officers. | N/A no CRD number reported |
| EDGAR ↗ | Nov 1, 2018 D File 021-324879 | $610,000 | $0 | $0 | T.R. Winston & Company, LLC BrokerCheck CRD 10571 ↗ |
| EDGAR ↗ | Oct 14, 2016 D File 021-272576 | $0 | $600,000 (est.) | $1,000,000 (est.) Annual compensation of executive officers and directors over the next year is expected to be approximately $1 million. | None listed on this filing |
| EDGAR ↗ | Jan 20, 2016 D File 021-255608 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 8, 2016 D/A File 021-225542 | $0 | $0 | $478,000 (est.) Working capital including salaries for officers | None listed on this filing |
| EDGAR ↗ | Sep 30, 2014 D File 021-225540 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 30, 2014 D File 021-210971 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 2, 2013 D/A File 021-203481 | $880,638 (est.) | $0 | $0 (est.) | T.R. Winston & Company LLC BrokerCheck CRD 10571 ↗ via More than five (5) Associated Persons |
| EDGAR ↗ | Sep 17, 2013 D File 021-203013 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 14, 2013 D File 021-198008 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 12, 2013 D File 021-193086 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 14, 2012 D File 021-188439 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 7, 2012 D File 021-183758 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 2, 2011 D File 021-168169 | $210,000 (est.) | $0 (est.) | $0 | Monarch Capital Group, Inc. no CRD number reported CIM Securities, LLC no CRD number reported |
| EDGAR ↗ | Oct 26, 2011 D File 021-167841 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 18, 2011 D File 021-167470 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 26, 2011 D File 021-166395 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 27, 2011 D File 021-160475 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 9, 2011 D/A File 021-155547 | $105,000 (est.) | $0 (est.) | $0 | Monarch Capital Group, Inc. no CRD number reported Antaeus Capital, Inc. no CRD number reported |
| EDGAR ↗ | Apr 4, 2011 D File 021-157780 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 18, 2010 D File 021-149246 | $66,000 (est.) | $0 | $0 | Monarch Capital Group LLC no CRD number reported |
| EDGAR ↗ | Aug 3, 2010 D/A File 021-143748 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 18, 2010 D File 021-134238 | $0 | $0 | $0 | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across all 3 issuers in this group — every filing in our index, latest filing per offering (SEC file number).
0 recorded documents and 0 ownership records matched to Emmaus Life Sciences in the sources searched.
Not found in sources searched as of Oct 23, 2026, 8:59 PM ET: Hillsborough County FL Clerk of Court Official Records daily index (publicrec.hillsclerk.com D/P/M files), 2 daily files (Oct 14, 2026 to Oct 15, 2026) — loaded Oct 23, 2026, 8:59 PM ET; Florida DOR NAL roll (Hillsborough 39) roll year 2026 — loaded Oct 23, 2026, 8:54 PM ET; Florida DOR NAL roll (Dade 23) roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET; Harris County Appraisal District real_acct.txt roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET; Dallas Central Appraisal District ACCOUNT_INFO.CSV roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET. Not yet searched for this group (queued): NYC ACRIS via NYC Open Data (Real Property Parties 636b-3b5g, Master bnx9-e6tj, Legals 8h5j-fqxa, Document Control Codes 7isb-wh4c) · NYC PLUTO ownership via NYC Open Data (64uk-42ks) · Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp). Records in other counties, and recorder indexes we do not yet cover, were not searched.
Property records coverage: New York City (ACRIS recorded documents and PLUTO ownership, looked up per issuer when its page is viewed; re-checked when the page is viewed again more than 30 days after the last check); Hillsborough County FL (recorded documents from Oct 14, 2026 forward; ownership from FL DOR roll 2026); Cook County IL (assessor ownership and deed/sale records, looked up per issuer when its page is viewed); Harris County TX and Dallas County TX (assessor ownership rolls only, 2026 roll; no deed, mortgage or sale records); Miami-Dade County FL (ownership from FL DOR roll only; Clerk recorded documents not yet searched). Recorder indexes for TX, AZ, IL and WA counties, mortgages and liens outside NYC and FL, lis pendens and foreclosure notices everywhere, Miami-Dade County FL recorded documents, Maricopa County AZ, King County WA, Salt Lake County UT, and all other counties are not yet searched. Last refresh by source: Hillsborough County FL Clerk daily index Oct 23, 2026, 8:59 PM ET; Dallas Central Appraisal District ACCOUNT_INFO.CSV Oct 23, 2026, 8:58 PM ET; Harris County Appraisal District real_acct.txt Oct 23, 2026, 8:58 PM ET; Florida DOR NAL roll (Dade 23) Oct 23, 2026, 8:58 PM ET; Florida DOR NAL roll (Hillsborough 39) Oct 23, 2026, 8:54 PM ET. NYC and Cook County are looked up per issuer when its page is viewed; the most recent such lookup on this site finished Oct 24, 2026, 1:51 AM ET. Parties are named as the recorder's index names them (role suffixes as recorded); no address, account number or trust date is shown for an individual, and individual owners of record (home ownership) are not matched or shown. Items still in human review are not shown.
Why each issuer is here is stated in the "Linked by" column. Low-confidence links are never shown — they wait for human review.
| Source | Issuer | Linked by | Location | Industry | Filings | Sold (max) | Investors | Min. investment (latest filing) | Active |
|---|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | Emmaus Life Sciences, Inc. | shared people, similar issuer names | TORRANCE, CA | Pharmaceuticals | 29 | $4,000,000 offering $235,000 · similar: $1,694,259–$16,000,000 | 19 similar: 1–13 | No minimum reported similar: $10,000–$55,000 | 2009–2023 |
| EDGAR ↗ | EMMAUS LIFE SCIENCES, INC. | shared people, similar issuer names | TORRANCE, CA | Pharmaceuticals | 9 | $20,000,000 offering Indefinite · similar: $1,500,000–$10,000,000 | 318 similar: not enough data | No minimum reported similar: not enough data | 2011–2019 |
| EDGAR ↗ | EMMAUS MEDICAL INC | shared people, similar issuer names | TORRANCE, CA | Pharmaceuticals | 1 | $1,153,750 | 21 | No minimum reported | 2011–2011 |
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); Pharmaceuticals / 506(c) (33 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
| Source | Filed | Issuer | Form | Industry | Offered | Sold |
|---|---|---|---|---|---|---|
| EDGAR ↗ | Jan 31, 2023 | Emmaus Life Sciences, Inc. | D | Pharmaceuticals | $235,000 | $0 |
| EDGAR ↗ | Jan 20, 2023 | Emmaus Life Sciences, Inc. | D | Pharmaceuticals | $34,000,000 | $0 |
| EDGAR ↗ | Jun 30, 2022 | Emmaus Life Sciences, Inc. | D | Pharmaceuticals | $220,000 | $110,000 |
| EDGAR ↗ | Feb 16, 2021 | Emmaus Life Sciences, Inc. | D | Pharmaceuticals | $17,000,000 | $1,920,000 |
| EDGAR ↗ | Oct 9, 2020 | Emmaus Life Sciences, Inc. | D/A | Pharmaceuticals | $3,840,300 | $3,840,300 |
| EDGAR ↗ | Oct 7, 2020 | Emmaus Life Sciences, Inc. | D/A | Pharmaceuticals | $3,680,800 | $3,680,800 |
| EDGAR ↗ | Oct 7, 2020 | Emmaus Life Sciences, Inc. | D | Pharmaceuticals | $3,680,800 | $0 |
| EDGAR ↗ | Aug 7, 2020 | Emmaus Life Sciences, Inc. | D | Pharmaceuticals | $1,895,000 | $947,600 |
| EDGAR ↗ | Apr 1, 2019 | EMMAUS LIFE SCIENCES, INC. | D | Pharmaceuticals | Indefinite | $2,585,000 |
| EDGAR ↗ | Nov 1, 2018 | EMMAUS LIFE SCIENCES, INC. | D | Pharmaceuticals | $12,200,000 | $12,200,000 |
| EDGAR ↗ | Oct 14, 2016 | EMMAUS LIFE SCIENCES, INC. | D | Pharmaceuticals | $20,000,000 | $20,000,000 |
| EDGAR ↗ | Jan 20, 2016 | EMMAUS LIFE SCIENCES, INC. | D | Pharmaceuticals | $40,000,000 | $1,700,000 |
| EDGAR ↗ | Jan 8, 2016 | Emmaus Life Sciences, Inc. | D/A | Other Health Care | $6,000,000 | $4,000,000 |
| EDGAR ↗ | Jul 2, 2015 | Emmaus Life Sciences, Inc. | D/A | Other Health Care | $3,000,000 | $2,265,000 |
| EDGAR ↗ | Sep 30, 2014 | Emmaus Life Sciences, Inc. | D | Other Health Care | $2,500,000 | $1,550,000 |
| EDGAR ↗ | Sep 30, 2014 | Emmaus Life Sciences, Inc. | D | Other Health Care | $1,000,000 | $260,000 |
| EDGAR ↗ | Jan 30, 2014 | Emmaus Life Sciences, Inc. | D | Other Health Care | $1,000,000 | $415,000 |
| EDGAR ↗ | Oct 2, 2013 | EMMAUS LIFE SCIENCES, INC. | D/A | Pharmaceuticals | $7,551,253 | $7,551,253 |
| EDGAR ↗ | Sep 24, 2013 | EMMAUS LIFE SCIENCES, INC. | D | Pharmaceuticals | $7,551,253 | $7,551,253 |
| EDGAR ↗ | Sep 17, 2013 | Emmaus Life Sciences, Inc. | D | Other Health Care | $2,000,000 | $221,549 |
| EDGAR ↗ | Jun 14, 2013 | Emmaus Life Sciences, Inc. | D | Other Health Care | $2,000,000 | $72,500 |
| EDGAR ↗ | Mar 12, 2013 | Emmaus Life Sciences, Inc. | D | Other Health Care | $2,500,000 | $595,000 |
| EDGAR ↗ | Dec 14, 2012 | Emmaus Life Sciences, Inc. | D | Other Health Care | $135,846 | $135,846 |
| EDGAR ↗ | Sep 7, 2012 | Emmaus Life Sciences, Inc. | D | Other Health Care | $2,000,000 | $300,000 |
| EDGAR ↗ | Nov 2, 2011 | Emmaus Life Sciences, Inc. | D | Other Health Care | $2,000,000 | $270,000 |
| EDGAR ↗ | Oct 26, 2011 | Emmaus Life Sciences, Inc. | D | Other Health Care | $0 | $0 |
| EDGAR ↗ | Oct 18, 2011 | EMMAUS LIFE SCIENCES, INC. | D | Pharmaceuticals | $3,715,079 | $3,715,079 |
| EDGAR ↗ | Sep 26, 2011 | EMMAUS LIFE SCIENCES, INC. | D | Pharmaceuticals | Indefinite | $0 |
| EDGAR ↗ | May 27, 2011 | EMMAUS MEDICAL INC | D | Pharmaceuticals | $1,153,750 | $1,153,750 |
| EDGAR ↗ | May 9, 2011 | Emmaus Life Sciences, Inc. | D/A | Other Health Care | $2,500,000 | $2,500,000 |
| EDGAR ↗ | Apr 4, 2011 | EMMAUS LIFE SCIENCES, INC. | D | Other | $1,200,000 | $1,013,500 |
| EDGAR ↗ | Feb 17, 2011 | Emmaus Life Sciences, Inc. | D | Other Health Care | $5,000,000 | $450,000 |
| EDGAR ↗ | Oct 18, 2010 | Emmaus Life Sciences, Inc. | D | Other Health Care | $3,050,000 | $1,611,688 |
| EDGAR ↗ | Aug 3, 2010 | Emmaus Life Sciences, Inc. | D/A | Other Health Care | $1,000,000 | $750,000 |
| EDGAR ↗ | Jun 18, 2010 | Emmaus Life Sciences, Inc. | D | Other Health Care | $500,000 | $500,000 |
| EDGAR ↗ | Mar 18, 2010 | Emmaus Life Sciences, Inc. | D | Other Health Care | $1,000,000 | $1,000,000 |
| EDGAR ↗ | Mar 17, 2010 | Emmaus Life Sciences, Inc. | D | Other Health Care | $400,000 | $200,000 |
| EDGAR ↗ | Mar 17, 2010 | Emmaus Life Sciences, Inc. | D | Other Health Care | $500,000 | $500,000 |
| EDGAR ↗ | Sep 8, 2009 | Emmaus Life Sciences, Inc. | D | Other Health Care | $6,426,000 | $2,043,000 |
Activity: 0 new offerings in the last 12 months across all issuers in this group (new offering = a Form D that is not an amendment, D/A) · most recent filing Jan 31, 2023. Industry history, as reported on each offering's latest filing: Previous offerings: Other Health Care (2009–2011), Other (2011), Pharmaceuticals (2011), Other Health Care (2011–2013), Pharmaceuticals (2013), Other Health Care (2014). Latest offering: Pharmaceuticals (2016–2023; most recent Jan 31, 2023).
| Name | Roles | Issuers here | First → last listed |
|---|---|---|---|
| Yutaka Niihara | Executive Officer, Director | 3 | May 27, 2011 → Jan 31, 2023 |
| Willis Lee | Executive Officer, Director | 3 | May 27, 2011 → Jan 31, 2023 |
| Yasushi Nagasaki | Executive Officer | 3 | May 27, 2011 → Jan 31, 2023 |
| Ian Zwicker | Director | 2 | Jan 20, 2016 → Jan 31, 2023 |
| Wei Peu Zen | Director | 2 | Nov 1, 2018 → Jan 31, 2023 |
| Robert Dickey | Director | 2 | Nov 1, 2018 → Jun 30, 2022 |
| Masaharu Osato | Director | 2 | Jan 20, 2016 → Jun 30, 2022 |
| Lan T. Tran | Executive Officer | 2 | May 27, 2011 → Apr 1, 2019 |
| Maurice J. DeWald | Director | 2 | Sep 26, 2011 → Oct 2, 2013 |
| Charles Stark | Executive Officer | 1 | Jun 30, 2022 → Jan 31, 2023 |
| George Sekulich | Executive Officer | 1 | Jun 30, 2022 → Jan 31, 2023 |
| Lim Seah | Director | 1 | Jan 20, 2023 → Jan 31, 2023 |
| Jane Pine Wood | Director | 1 | Aug 7, 2020 → Feb 16, 2021 |
| Joseph Sherwood | Executive Officer | 1 | Aug 7, 2020 → Oct 9, 2020 |
| Kurt Kruger | Executive Officer | 1 | Nov 1, 2018 → Apr 1, 2019 |
| Peter Ludlum | Executive Officer | 1 | Sep 24, 2013 → Oct 14, 2016 |
| Jon Kuwahara | Director | 1 | Jan 20, 2016 → Oct 14, 2016 |
| Geoffrey Harris | Director | 1 | Jan 8, 2016 → Jan 8, 2016 |
| George Carpenter | Executive Officer, Director | 1 | Sep 8, 2009 → Jan 8, 2016 |
| John Pappajohn | Director | 1 | Mar 17, 2010 → Jan 8, 2016 |
| Paul Buck | Executive Officer | 1 | Mar 17, 2010 → Jan 8, 2016 |
| Zachary McAdoo | Director | 1 | Sep 7, 2012 → Jan 8, 2016 |
| Andrew Sassine | Director | 1 | Mar 12, 2013 → Jan 8, 2016 |
| Robert Follman | Director | 1 | Mar 12, 2013 → Jan 8, 2016 |
| Michal Votruba | Director | 1 | Jan 8, 2016 → Jan 8, 2016 |
| Robin Smith | Director | 1 | Jan 8, 2016 → Jan 8, 2016 |
| Richard Turner | Director | 1 | Mar 12, 2013 → Sep 30, 2014 |
| Thomas Tierney | Director | 1 | Mar 12, 2013 → Sep 30, 2014 |
| Walter Schindler | Director | 1 | Dec 14, 2012 → Sep 30, 2014 |
| Tracey C. Doi | Director | 1 | Sep 26, 2011 → Oct 2, 2013 |
| Henry A. McKinnell | Director | 1 | Sep 26, 2011 → Oct 2, 2013 |
| Daniel Hoffman | Executive Officer | 1 | Sep 8, 2009 → Dec 14, 2012 |
| Michael Darkoch | Executive Officer | 1 | Aug 3, 2010 → Dec 14, 2012 |
| David B. Jones | Director | 1 | Sep 8, 2009 → Sep 7, 2012 |
| Henry T. Harbin | Director | 1 | Sep 8, 2009 → Sep 7, 2012 |
| George Kallins | Director | 1 | Aug 3, 2010 → Sep 7, 2012 |
| Jerome Vaccaro | Director | 1 | Sep 8, 2009 → Nov 2, 2011 |
| AMIR HESHMATPOUR | Executive Officer, Director | 1 | Apr 4, 2011 → Oct 18, 2011 |
| Alfred E. Osborne Jr. | Director | 1 | Sep 26, 2011 → Oct 18, 2011 |
| Henry McKinnel, Jr. | Director | 1 | May 27, 2011 → May 27, 2011 |
| Douglas Wilmore | Director | 1 | May 27, 2011 → May 27, 2011 |
| TIMOTHY J BRASEL | Executive Officer, Director | 1 | Apr 4, 2011 → Apr 4, 2011 |
| TOMMY THOMPSON | Director | 1 | Mar 17, 2010 → Mar 18, 2010 |
| Len Brandt | Director | 1 | Sep 8, 2009 → Sep 8, 2009 |
| Mark Desrosiers | Executive Officer | 1 | Sep 8, 2009 → Sep 8, 2009 |
Not yet searched. Sources to be searched: SEC Investment Adviser Information Reports — Form ADV data for SEC-registered advisers and exempt reporting advisers (file dated 2026-10-02); SEC Investment Adviser Public Disclosure (IAPD) firm search — registered and exempt reporting advisers · Search queued. Results are added automatically; check back later.
Not yet searched.
Sources to be searched: the sponsor's website (none on record yet; a sponsor's website is known only from the issuer's own filings (Form C issuer website; EDGAR company profile), an approved profile claim or Form ADV Item 1.I of its matched adviser — we never look it up elsewhere) for Meta Pixel ids and Facebook / Instagram page links; Meta Ad Library API: not yet searched (API access pending). We never read facebook.com or instagram.com; readers get a link to Meta's public Ad Library instead.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period) · Premium
Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".
No corrections have been requested for this page.
Free. Covers the grouping itself or any record shown here. Logged with status: received → under review → fixed / confirmed with source.
Add a sourced explanation next to any fact. Reviewed before publishing.